REG4 is thought to be an early stage serum biomarker of gastric cancer metastasis (Tao et al., 2011) and resistance to apoptosis after treatment with 5-fluorouracil (5-FU) used for chemotherapy (Mitani et al., 2007). This evidence concerns the gene REG4 and gastric cancer.